Cargando…
Targeted Diphtheria Toxin-Based Therapy: A Review Article
Cancer remains one of the leading causes of death worldwide. Conventional therapeutic strategies usually offer limited specificity, resulting in severe side effects and toxicity to normal tissues. Targeted cancer therapy, on the other hand, can improve the therapeutic potential of anti-cancer agents...
Autores principales: | Shafiee, Fatemeh, Aucoin, Marc G., Jahanian-Najafabadi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813239/ https://www.ncbi.nlm.nih.gov/pubmed/31681205 http://dx.doi.org/10.3389/fmicb.2019.02340 |
Ejemplares similares
-
Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: An attempt for production of a new vaccine against diphtheria
por: Shafiee, Fatemeh, et al.
Publicado: (2016) -
Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin
por: Havaei, Seyed Mehdi, et al.
Publicado: (2021) -
Optimization of the Expression of DT386-BR2 Fusion Protein in Escherichia coli using Response Surface Methodology
por: Shafiee, Fatemeh, et al.
Publicado: (2017) -
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
por: Ghavimi, Reza, et al.
Publicado: (2020) -
Expression, purification, and cytotoxic evaluation of IL24-BR2 fusion protein
por: Pourhadi, Marjan, et al.
Publicado: (2019)